Companies ›Basic Materials ›300398.SZ

300398.SZ — Shenzhen Stock Exchange Specialty Chemicals

PhiChem Corp

¥40,15

Open in Charts → Attach watcher ⌖

— —

CNY

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

0,38 %

Op margin

14,6 %

ROE

8,0 %

Net margin

12,1 %

Debt / equity

0,22

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

PhiChem Corp is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Business. PhiChem Corp (300398.SZ) is a specialty chemicals company listed on the Shenzhen Stock Exchange. The firm operates within the Basic Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level as a participant in the specialty chemicals market.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustrySpecialty Chemicals

ActivityChemicals

Generated · model-assisted

Sell-side consensus

BUY1 analysts

1 buy0 hold0 sell

Avg 12m price target31,82

Analyst recommendations

1 analysts · consensus Buy

Buy1

Hold0

Sell0

12-month price target

31,82

Consensus of sell-side coverage.

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Buy

1 analysts · indicative

Ownership

—

not yet wired

Profitability→

8,0 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning 300398.

Sector rotation

Sector1D1Mvs mkt

Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to 300398.SZ. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

PhiChem Corp (300398.SZ) is a specialty chemicals company listed on the Shenzhen Stock Exchange. The firm operates within the Basic Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level as a participant in the specialty chemicals market.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustrySpecialty Chemicals

ActivityChemicals

AI synthesis

GENERATED

PhiChem Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.22, significantly below the industry median for specialty chemicals firms. The company's liquidity position is characterized by a current ratio of 2.18, indicating sufficient short-term assets to cover liabilities. However, the firm has negative net cash after subtracting total debt, signaling potential liquidity constraints.

Profitability metrics show PhiChem Corp generating a return on equity (ROE) of 7.95% and a return on assets (ROA) of 5.57%. These figures are below the industry median for specialty chemicals, suggesting room for improvement in asset utilization and capital efficiency.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. No material revenue concentration by geography is reported, but the absence of segmental breakdowns limits visibility into operational risk.

PhiChem Corp's growth trajectory is constrained by negative free cash flow of 58.1 million CNY and capital expenditures of -493.9 million CNY. The firm is not currently generating positive cash flow from operations to support growth initiatives. Analysts have assigned a mean recommendation of 2.00, indicating a neutral outlook with no strong buy ratings.

Risk factors include medium liquidity risk due to negative net cash and low dilution risk, as the firm has not issued additional shares in the recent period. No dilution sources are identified in the latest filings, and the company's capital structure remains stable.

Recent events include a single analyst buy rating and a mean price target of 31.82 CNY. No material earnings call transcripts or regulatory filings have been disclosed in the latest period. The firm's financial performance remains consistent with prior quarters, with no significant operational or strategic changes reported.

Key takeaways

PhiChem Corp has a conservative debt-to-equity ratio of 0.22 but faces liquidity constraints due to negative net cash.
ROE of 7.95% and ROA of 5.57% indicate below-median profitability for the specialty chemicals industry.
The company lacks geographic and segmental diversification, increasing operational risk.
Negative free cash flow and capital expenditures suggest limited capacity for growth.
Analysts have assigned a neutral outlook with no strong buy ratings and a mean price target of 31.82 CNY.
No dilution sources are identified, and the firm maintains a stable capital structure.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

¥40,15

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

¥4.91B

Net cashⓘ

-¥1.08B

Current ratioⓘ

2.2

Debt / equityⓘ

0.2

ROAⓘ

5.6%

ROEⓘ

8.0%

Cash conversionⓘ

171.0%

CapEx / revenueⓘ

-15.3%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

0,86

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-21 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Full fiscal year~1 year ahead

Full fiscal year · our forecast vs guidance vs consensus

Metric	Our forecast	Guidance	Consensus
EPS	—no estimate	—no estimate	0,86
Revenue	—no estimate	—no estimate	3,6B CNY
Operating income	—no estimate	—no estimate	—no estimate

Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution1 analysts

Strong buy0

Buy1

Hold0

Sell0

Strong sell0

12-month price target¥31,82 · Median ¥31,82

Low ¥31,82High ¥31,82

EPS surprise

−17,4 %

reported vs consensus · miss

Revenue surprise

−9,4 %

reported vs consensus · miss

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low¥31,82

Mean¥31,82

Median¥31,82

High¥31,82

Spot¥40,15

−20.7 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin14,6 %Above P75

Net Margin12,1 %Above P75

ROE8,0 %Above median

Capex / Rev-15,3 %Bottom quartile

D/E0,22Above median

Cash Conv1,71Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

PhiChem Corp Market data — financials · 2026-05-26
PhiChem Corp Market data — analyst estimates · 2026-05-26

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

300398.SZCanonical

Shenzhen Stock Exchange · CNY

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread